We are living in a time of rapid change.
With more than 76% of sponsors beginning to decentralize their trials, Medable recognizes the shifts taking place today.
However, how organizations prepare today, determines how well they'll perform tomorrow.
Join Medable for a discussion on DCT adaptation from a scientific, operational, and innovative technology perspective. We'll identify how to transform drug development into a new era of digitally enabled, decentralized solutions that make research access ubiquitous to all.
Experienced drug development professional with a demonstrated history of working across multiple business areas within the research industry
Rasmus Hogreffe, MSc.Med., MBA is considered as a Virtual Clinical Trials expert. His main goal is to improve treatment for patients by...